MedPath

New-DES vs BMS in SVG -1 Year Outcomes

Completed
Conditions
Coronary Artery Disease
Interventions
Device: new-DES
Device: BMS
Registration Number
NCT04338308
Lead Sponsor
Medical University of Silesia
Brief Summary

Data regarding the efficacy of the percutaneous coronary intervention (PCI) with new-designed drug-eluting stent (new-DES) vs. bare metal stent (BMS) of saphenous vein grafts (SVG) stenosis is scarce. The primary objective was to compare one-year clinical outcomes of PCI in stenosis of SVG using new-DES vs. BMS in a real-world population. We carried out a multi-center registry comparing new-DES with BMS in all consecutive patients undergoing PCI of SVG. The primary composite endpoint was major adverse cardiac and cerebrovascular events (MACCE) at 1 year.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
792
Inclusion Criteria
  • patients after CABG with significant SVG stenosis referred for PCI
Exclusion Criteria
  • patients who had both types of stents implanted in the same procedure
  • patients with the old-DES
  • patients who had PCI of other vascular territories during the same procedure

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
SVG PCInew-DES-
SVG PCIBMS-
Primary Outcome Measures
NameTimeMethod
major adverse cardiac and cerebrovascular event1 year
Secondary Outcome Measures
NameTimeMethod
stroke1 year
target lesion revascularization1 year
death1 year
myocardial infarction1 year
target vessel revascularization1 year

Trial Locations

Locations (3)

First Department of Cardiology, Medical University of Gdansk, Gdansk, Poland

🇵🇱

Gdańsk, Poland

Second Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland

🇵🇱

Kraków, Poland

Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland

🇵🇱

Katowice, Poland

© Copyright 2025. All Rights Reserved by MedPath